September 14, 2015

Hatchtech will pay Dr. Reddy’s $10 million upfront and potentially as much as $50 million based on milestones linked to sales targets. 

September 14, 2015

The Perrigo offer notwithstanding, Mylan is committed and well-positioned to pursue the OTC segment independently given its global scale and capabilities, company says. 

September 11, 2015

Repatha is one in a new class of cholesterol medications called PSCK9 (proprotein convertase substilisin kexin type 9) inhibitors, which are potentially an alternative to statins.

September 11, 2015

Egalet Corporation on Thursday launched (oxycodone HCI) in the U.S.

September 11, 2015

Mission Pharmacal announced Friday that it would be relaunching its Lithostat (acetohydroxamic acid) kidney stones treatment.

September 11, 2015

A new study by healthcare provider Kaiser Permanente’s research division published in the Journal of the American Informatics Association is highlighting the positive effects online prescription refills have on adherence.

September 11, 2015

Using Xerox’s prescription clinical authorization tool, pharmacists can investigate whether a patient recently received an opioid prescription and will receive a notice to acquire prior authorization before dispensing it. 

September 10, 2015

However, patients in the 10-17 years age group also showed the greatest improvement in appropriate prescription drug use compared to all other age groups over a four-year period.

September 10, 2015

Purdue Pharma this week announced that it had VM902A, acquired an allosteric selective tropmyosin receptor kinase A (TrkA) inhibitor, from VM Pharma.

September 9, 2015

The research found a 1% increase in overall prescription drug use was associated with decreases in non-prescription drug medical costs for three distinct groups of Medicaid beneficiaries.

September 9, 2015

Customer-to-customer will be the next stage of business model evolution in healthcare, according to Frost & Sullivan.

September 8, 2015

The Centers for Disease Control and Prevention has launced its new program, “Prescription Drug Overdose: Prevention for States,” which aims to invest in 16 states currently battling an epidemic of prescription drug overdoses. 

September 8, 2015

Data from recent years suggests that the increasing prevalence of diabetes may be leveling off.

September 8, 2015

Under the terms of the offer, Perrigo shareholders would receive $75 in cash and 2.3 Mylan ordinary shares for each Perrigo ordinary share.

September 8, 2015

The program asks individuals living with pain and providers to design the ideal experience in the exam room that would foster dialogue about prescription drug abuse, deterrent technology and the effect of pain.

September 8, 2015

Vernalis Therapeutics announced Tuesday that its Tuzistra XR (codeine polistirex and chlorpheniramine polistirex) extended release syrup has been made available ahead of cold and flu season. 

September 4, 2015

AstraZeneca on Thursday announced that the Food and Drug Administration approved Brilinta (ticagrelor) tablets at a 60 mg dose for patients with a history of heart attack beyond the first year.

September 4, 2015

The Food and Drug Administration this week approved expanded labeling for Janssen Biotech’s rheumatoid arthritis treatment Simponi Aria (golimumab for infusion).

September 4, 2015

The findings from a study published in this month’s issue of Clinical Infectious Diseases tout the effectiveness of HIV pre-exposure prophylaxis (PrEP), marketed as Truvada (tenofovir/embtricitabine) medication.

September 2, 2015

he campaign is being undertaken in partnership with the American Chronic Pain Association, the Pain Community, the U.S. Pain Foundation and the American Academy of Pain Management.

September 2, 2015

The collaboration will see them working on a BACE inhibitor program to treat Alzheimer’s disease and developing Amgen’s migraine drugs.

September 2, 2015

Sandoz on Wednesday introduced rivastigmine transdermal system, a generic version of Exelon Patch1, in the United States.

September 1, 2015

PrescribeMedicare is meant to serve as a tool for patients in 2016 when open enrollment for plan choices begins.

September 1, 2015

The company said the patch is a potential solution for the 73% of migraine sufferers who experience nausea with their migraines.